Opening moments of games can often feel long and slow, and may even be boring as the game must teach you how to play it first thing. They’re a necessary evil, but there's a new high bar, as the new ...

Greysun is the Lead Guides Editor at GameRant, where he oversees game help coverage for everything from the biggest AAA releases to standout indie and live-service titles. Professionally, Greysun has ...

Europe's Copernicus Sentinel-2 satellite mission captured this stunning image of south-central Morocco, showing the the city of Ouarzazate, the Anti-Atlas Mountains, and the Ouarzazate solar power ...

Jennings provided 2026 guidance: "We expect revenue within the range of $1.4 billion to $1.5 billion with adjusted gross margin between 26% and 27%." Adjusted EBITDA for 2026 is projected at $200 ...

Neutral-atom arrays are a rapidly emerging platform to create quantum computers. In a foundational study led by graduate students Aaron Holman and Yuan Xu from the Will and Yu labs, respectively, the ...

For some, Halloween is starting to rival Christmas for setting up elaborate holiday decorations. Homeowners now spend many hours─and sometimes dollars─creating ghoulish displays of lit pumpkins, ...

Qualcomm announced Tuesday it will acquire Arduino for undisclosed terms. The chipmaker said the Italy-based company would become an independent subsidiary of Qualcomm. In this article Qualcomm wants ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Here are the most important concepts developers must know when they size Java arrays and deal ...

Anne McClain and Nichole Ayers achieved most of their planned tasks on today's (May 1) 5-hour, 44-minute extravehicular activity. When you purchase through links on our site, we may earn an affiliate ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Oso Semiconductor, a developer of power-efficient, high-performance, low-cost chipsets for next generation wireless communication and sensing applications, ...

In the years after the 2020 COVID-19 pandemic, it is clear that mRNA as a modality for vaccines and therapeutics is here to stay based on the number of mRNA programs currently in clinical development.